CN101503373A - 2-氨基-1-(4-硝基苯基)-1-乙醇类金属蛋白酶抑制剂及其制备方法和用途 - Google Patents

2-氨基-1-(4-硝基苯基)-1-乙醇类金属蛋白酶抑制剂及其制备方法和用途 Download PDF

Info

Publication number
CN101503373A
CN101503373A CNA2009100198172A CN200910019817A CN101503373A CN 101503373 A CN101503373 A CN 101503373A CN A2009100198172 A CNA2009100198172 A CN A2009100198172A CN 200910019817 A CN200910019817 A CN 200910019817A CN 101503373 A CN101503373 A CN 101503373A
Authority
CN
China
Prior art keywords
amino
hydroxyl
nitrophenyl
compound
propyl group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CNA2009100198172A
Other languages
English (en)
Chinese (zh)
Other versions
CN101503373B (zh
Inventor
徐文方
杨康辉
方浩
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shandong University
Original Assignee
Shandong University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shandong University filed Critical Shandong University
Priority to CN2009100198172A priority Critical patent/CN101503373B/zh
Publication of CN101503373A publication Critical patent/CN101503373A/zh
Application granted granted Critical
Publication of CN101503373B publication Critical patent/CN101503373B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
CN2009100198172A 2009-03-13 2009-03-13 2-氨基-1-(4-硝基苯基)-1-乙醇类金属蛋白酶抑制剂及其制备方法和用途 Expired - Fee Related CN101503373B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2009100198172A CN101503373B (zh) 2009-03-13 2009-03-13 2-氨基-1-(4-硝基苯基)-1-乙醇类金属蛋白酶抑制剂及其制备方法和用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2009100198172A CN101503373B (zh) 2009-03-13 2009-03-13 2-氨基-1-(4-硝基苯基)-1-乙醇类金属蛋白酶抑制剂及其制备方法和用途

Publications (2)

Publication Number Publication Date
CN101503373A true CN101503373A (zh) 2009-08-12
CN101503373B CN101503373B (zh) 2013-07-24

Family

ID=40975766

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2009100198172A Expired - Fee Related CN101503373B (zh) 2009-03-13 2009-03-13 2-氨基-1-(4-硝基苯基)-1-乙醇类金属蛋白酶抑制剂及其制备方法和用途

Country Status (1)

Country Link
CN (1) CN101503373B (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009109850A3 (fr) * 2008-03-06 2009-12-10 Novaremed Ltd. Procédé de traitement ou de prévention de la douleur
US8252843B2 (en) 2004-03-26 2012-08-28 Novaremed Limited Compounds for the treatment of AIDS and other viral diseases
US8309606B2 (en) 2002-10-03 2012-11-13 Novaremed Limited Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
WO2013026942A1 (fr) 2011-08-25 2013-02-28 The Provost, Fellows, Foundation Scholars, And The Other Members Of Board, Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin Agents de liaison à la tubuline
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
EP3964497A1 (fr) * 2020-09-04 2022-03-09 Friedrich-Alexander-Universität Erlangen-Nürnberg Composés de diamine vicinale substitués et leur utilisation dans le traitement, l'amélioration ou la prévention de la douleur

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1566065A (zh) * 2003-06-27 2005-01-19 中国医学科学院药物研究所 α位杂原子取代的γ芳基丁本酮酸衍生物及其制法和其药物组合物与用途

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8309606B2 (en) 2002-10-03 2012-11-13 Novaremed Limited Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection
US8252843B2 (en) 2004-03-26 2012-08-28 Novaremed Limited Compounds for the treatment of AIDS and other viral diseases
WO2009109850A3 (fr) * 2008-03-06 2009-12-10 Novaremed Ltd. Procédé de traitement ou de prévention de la douleur
US8883853B2 (en) 2008-03-06 2014-11-11 Novaremed Limited N-substituted benzenepropanamide or benzenepropenamide derivatives for use in the treatment of pain and inflammation
US8802734B2 (en) 2009-09-09 2014-08-12 Novaremed Limited Method of treating or preventing pain
WO2013026942A1 (fr) 2011-08-25 2013-02-28 The Provost, Fellows, Foundation Scholars, And The Other Members Of Board, Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin Agents de liaison à la tubuline
EP3964497A1 (fr) * 2020-09-04 2022-03-09 Friedrich-Alexander-Universität Erlangen-Nürnberg Composés de diamine vicinale substitués et leur utilisation dans le traitement, l'amélioration ou la prévention de la douleur
WO2022048922A1 (fr) * 2020-09-04 2022-03-10 Friedrich-Alexander-Universität Erlangen-Nürnberg Composés de diamine vicinale substitués et leur utilisation dans le traitement, l'atténuation ou la prévention de la douleur

Also Published As

Publication number Publication date
CN101503373B (zh) 2013-07-24

Similar Documents

Publication Publication Date Title
CN101503373B (zh) 2-氨基-1-(4-硝基苯基)-1-乙醇类金属蛋白酶抑制剂及其制备方法和用途
JP3455549B2 (ja) 血管損傷剤としてのコルヒノール誘導体の使用
CN101253148B (zh) 凝血酸的酰氧基烷基氨基甲酸酯前药，合成和使用的方法
CN101723896B (zh) 酪氨酸衍生物类组蛋白去乙酰化酶抑制剂及其应用
ES2270532T3 (es) Inhibidores de cisteina y serina proteasa a base de alfa-cetoamidas que contienen quinolina.
CN101817769B (zh) 脲基类肽氨肽酶n抑制剂及其应用
CN101357893B (zh) 乙二胺类金属蛋白酶抑制剂及其应用
JP2001520674A (ja) ペプチジル−２−アミノ−１−ヒドロキシアルカンスルホン酸システインプロテアーゼインヒビター
WO2021249234A1 (fr) Dérivé de benzothiazole et son utilisation
CN101481325B (zh) 碱性氨基酸类金属蛋白酶抑制剂及其应用
CN102199134A (zh) 噻二唑类组蛋白去乙酰化酶抑制剂及其应用
CN104592145A (zh) 一种苯并氧化呋咱组蛋白去乙酰化酶抑制剂及其制备方法和应用
CN103848795A (zh) 一种l,2,5-噁二唑-2-氧化物组蛋白去乙酰化酶抑制剂及其制备方法和应用
CN103172540B (zh) 苯甘氨酸类组蛋白去乙酰酶抑制剂及其制备方法和应用
CN100560568C (zh) 环酰亚胺类肽金属蛋白酶抑制剂及其应用
CN108409608A (zh) 芳香氮芥类组蛋白去乙酰化酶抑制剂及其制备方法和应用
CN107141244B (zh) 吲哚丁酸类组蛋白去乙酰酶抑制剂及其制备方法和应用
CN106496053B (zh) 一种组蛋白去乙酰酶抑制剂n‑(2’‑胺基苯基)‑4‑(双(2‑氯乙基)胺基)苯甲酰胺及其制备方法和应用
CN101538311B (zh) α-氨基酰环酰亚胺类肽金属蛋白酶抑制剂及其应用
CN105189469B (zh) 2-氨基-3,4-二氢喹唑啉衍生物及其作为组织蛋白酶d抑制剂的用途
ES2785313T3 (es) Acilguanidinas para el tratamiento de la artrosis
CN102276495B (zh) 3-氨基-2-羟基苯丙酸类金属蛋白酶抑制剂及其制备方法和应用
CA3105352A1 (fr) Derives d'acide (s)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoique et composes apparentes utilises en tant qu'inhibiteurs de caspase pour le traitement de maladies cardiovasculaires
CN105367479A (zh) 一种组蛋白去乙酰酶抑制剂2-(1-(4-氯苯甲酰基)-5-甲氧基-2-甲基-1氢-吲哚-3-基-n-(2-(羟氨基)-2-酮乙基)乙酰胺及其制备方法和应用
CN105348169B (zh) 一种组蛋白去乙酰酶抑制剂(e)‑3‑(2‑(1‑(4‑氯苯甲酰基)‑5‑甲氧基‑2‑甲基‑1氢‑吲哚‑3‑基)乙酰氨基)‑n‑羟基丁‑2‑烯酰胺及其制备方法和应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20130724

Termination date: 20160313

CF01 Termination of patent right due to non-payment of annual fee